HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Cash from Operations (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Cash from Operations came in at $93.7 million in Q2 2021, up 210.87% year-over-year from $30.1 million in Q2 2020, and up 519.02% quarter-over-quarter from -$22.4 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Cash from Operations (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Cash from Operations for 4 consecutive years, with $93.7 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Cash from Operations rose 210.87% year-over-year to $93.7 million in Q2 2021; TTM through Jun 2021 was $99.7 million, a 25.81% increase from a year earlier, with the FY2025 full-year figure at -$64.7 million, down 13109.46% from the prior year.
  • Cash from Operations was $93.7 million for Q2 2021 at HUTCHMED (China), up from -$22.4 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $93.7 million in Q2 2021 and troughed at -$22.4 million in Q1 2021.
  • A 4-year average of $17.8 million and a median of $15.7 million in 2018 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations jumped 10528.89% in 2019 and plunged 1172.4% in 2021, its largest moves.
  • Over 4 years, Cash from Operations stood at $13.9 million in 2018, then increased by 24.76% to $17.4 million in 2019, then soared by 73.32% to $30.1 million in 2020, then soared by 210.87% to $93.7 million in 2021.
  • The last three Cash from Operations figures came in at $93.7 million (Q2 2021), -$22.4 million (Q1 2021), and $30.1 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 210.98 Bn 196.99 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 181.24 Bn 178.06 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 132.38 Bn 124.53 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 82.97 Bn 74.97 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn -
6 Moderna 54.80 Bn 49.67 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 34.09 Bn 30.78 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.34 Bn 30.05 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn -270.50 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 93.68 Mn
Mar 31, 2021 -22.36 Mn
Jun 30, 2020 30.13 Mn
Mar 31, 2020 -1.76 Mn
Dec 31, 2019 17.39 Mn
Sep 30, 2019 33.48 Mn
Jun 30, 2019 1.12 Mn
Mar 31, 2019 28.92 Mn
Dec 31, 2018 13.94 Mn
Sep 30, 2018 315,000.00
Jun 30, 2018 -12.24 Mn
Mar 31, 2018 30.84 Mn